Khaitan Co advised Viatris, a global pharmaceutical company, on its proposed sale of stake in Biocon Biologics to Biocon for USD 815 million. This included USD 400 million in cash and USD 415 million through a share swap by way of preferential allotment.
The team comprised of Rabindra Jhunjhunwala (Partner), Abhishek Dadoo (Partner), Aman Anand (Principal Associate), Gaurang Mansinghka (Senior Associate) and Nitya Saxena (Associate) with assistance from the following:
Banking aspects: Rajeev Vidhani (Partner) and Krishnendu Sen (Counsel)
Antitrust aspects: Anisha Chand (Partner) and Yatharth Vardhan Singh (Senior Associate)
Taxation aspects: Ritu Shaktawat (Partner) and Husain Bohra (Senior Associate)
Capital markets aspects: Aditya Cheriyan (Partner) and Chirayu Chandani (Partner)